12250-7 |
Reticulocytes/1000 erythrocytes^^hematocrit adjusted |
NFr |
Bld |
Pt |
Qn |
|
|
DISCOURAGED |
Reticulocytes/1000 erythrocytes hematocrit adjusted in Blood |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
12250-7 |
|
|
|
|
Observation |
|
|
|
0 |
Retics/1000 RBC Hct adj NFr |
|
|
|
Y |
|
1000 RBC; adj; Blood; Discocytes; Erthrocyte; Erythrocyte; Hct; Hct adj; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number Fraction; PCV; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Retic; Retics; Reticulocyte; Reticulocyte Index; RI; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12251-5 |
Rubella virus Ag |
PrThr |
XXX |
Pt |
Ord |
IF |
|
ACTIVE |
Rubella virus Ag [Presence] in Specimen by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12251-5 |
|
IF |
|
|
Both |
|
|
|
0 |
RUBV Ag Spec Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Congenital rubella syndrome; DFA; FA; Fluorescent antibody; Fluoresent; German measles; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; RUBV; Screen; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified |
2.69 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12252-3 |
Somatomedin C |
MCnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHEM |
|
12252-3 |
|
|
|
|
|
|
|
|
0 |
Deprecated Somatomedin C Ser-mCnc |
|
|
|
|
|
Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.7 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12253-1 |
Somatotropin^baseline |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --baseline |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
12253-1 |
|
|
|
|
Observation |
|
|
|
0 |
GH BS SerPl-mCnc |
|
|
|
Y |
|
BS; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
12254-9 |
Specimen volume |
Vol |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Volume of Body fluid |
|
MIN |
DefinitionDescription |
|
|
liters;mL |
|
|
|
|
|
|
SPEC |
|
12254-9 |
|
|
|
|
Observation |
|
|
|
0 |
Specimen vol Fld |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Vol; Volume |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
L |
|
|
|
0 |
12255-6 |
Specimen volume |
Vol |
Urine |
5H |
Qn |
|
|
ACTIVE |
Volume of 5 hour Urine |
|
MIN |
DefinitionDescription |
|
|
L |
|
|
|
|
|
|
SPEC |
|
12255-6 |
|
|
|
|
Observation |
|
|
|
0 |
Specimen vol 5h Ur |
|
|
|
|
|
5 hours; 5.0Hr; 5HR; QNT; Quan; Quant; Quantitative; Spec; UA; UR; Urn; Vol; Volume |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
L |
|
|
|
0 |
12256-4 |
Spermatozoa^post vasectomy |
Naric |
Semen |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
|
MIN |
DefinitionDescription |
|
|
/HPF |
|
|
|
|
|
|
FERT |
|
12256-4 |
|
Microscopy.light.HPF |
|
|
Both |
|
|
|
0 |
Sperm p vas #/area Smn HPF |
|
|
|
Y |
|
#/area; After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Number areic; p vas; Point in time; Post vas; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; URO; Urology |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
12257-2 |
Spermatozoa.motile/Spermatozoa^post vasectomy |
NFr |
Semen |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Spermatozoa Motile/Spermatozoa in Semen by Microscopy high power field --post vasectomy |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
FERT |
|
12257-2 |
|
Microscopy.light.HPF |
|
|
Observation |
|
|
|
0 |
Sperm Motile p vas NFr Smn HPF |
|
|
|
Y |
|
After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Mot; Number fraction; p vas; Percent; Point in time; Post vas; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Motile; URO; Urology |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
12258-0 |
Epithelial cells.squamous |
PrThr |
Urine sed |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
12258-0 |
|
Microscopy.light |
|
|
Observation |
|
|
|
0 |
Squamous UrnS Ql Micro |
|
|
|
|
|
Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
Method was changed from 'Microscopy.light.HPF' to 'Microscopy.light'. Differentiating between HPF and LPF light microscopy for ordinal terms (present/absent) is not necessary.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12259-8 |
Streptococcus pyogenes enzyme Ab |
PrThr |
Ser |
Pt |
Ord |
Sheep cell aggl |
|
ACTIVE |
Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12259-8 |
|
Sheep cell aggl |
|
|
Both |
|
|
|
0 |
S pyog.enz Ab Ser Ql Shp Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Enz; Enzymes; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S pyog.enz; S pyogenes; Screen; Serum; Shp Aggl; SR; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; Streptozyme |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1226-0 |
M Ab |
PrThr |
Ser/Plas^BPU |
Pt |
Ord |
|
|
ACTIVE |
M Ab [Presence] in Serum or Plasma from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1226-0 |
|
|
|
|
Observation |
|
|
|
0 |
M Ab SerPl BPU Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); MNSs Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12260-6 |
Sucrose hemolysis |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Sucrose hemolysis [Presence] of Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
12260-6 |
|
|
|
|
Both |
|
|
|
0 |
Sucrose Hemolysis RBC Ql |
|
|
|
|
|
Erythrocytes; Hem; HEMATOLOGY/CELL COUNTS; Ordinal; PNH; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; SLT; Sucro; Sugar water test |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12261-4 |
Toxoplasma gondii Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IA |
|
ACTIVE |
Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
12261-4 |
|
IA |
|
|
Both |
|
|
|
0 |
T gondii IgG Titr Ser IA |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; T gondii; Titer; Titered; Titre; Toxo; Toxoplasmosis; Ttr |
2.75 |
1.0j-a |
|
|
|
|
|
|
|
{titer} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
12262-2 |
Toxoplasma gondii Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IA |
|
ACTIVE |
Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
12262-2 |
|
IA |
|
|
Both |
|
|
|
0 |
T gondii IgM Titr Ser IA |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; T gondii; Titer; Titered; Titre; Toxo; Toxoplasmosis; Ttr |
2.75 |
1.0j-a |
|
|
|
|
|
|
|
{titer} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
12263-0 |
Epstein Barr virus early diffuse Ab |
ACnc |
CSF |
Pt |
Ord |
IF |
|
DEPRECATED |
Deprecated EBV [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12263-0 |
|
IF |
|
|
Both |
|
|
|
0 |
Deprecated EBV EA-D Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EA; EA-D; EBV; EBV EA; EBV EA-D; Epstn; FA; Fluorescent antibody; Fluoresent; HHV-4; human herpesvirus 4; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Neuro; Neurology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.36 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12264-8 |
Epstein Barr virus early restricted Ab |
MCnc |
Body fld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Epstein Barr virus early restricted Ab [Mass/volume] in Body fluid |
|
DEL |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
12264-8 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated EBV EA-R Ab Fld-mCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; EA; EA-R; EBV; EBV EA; EBV EA-R; Epstn; Fl; Fld; FLU; Fluid; HHV-4; human herpesvirus 4; Level; Mass concentration; Mono; Mononucleosis; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.4 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12265-5 |
Urea nitrogen |
MCnc |
Periton fld |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Mass/volume] in Peritoneal fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
12265-5 |
|
|
|
|
Both |
|
|
|
0 |
Urea nit Prt-mCnc |
|
|
|
Y |
|
Ascites; Ascitic fluid; Ascitis; Blood urea nitrogen; Chemistry; Level; Mass concentration; N; N2; Nit; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; UN |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
12266-3 |
Urea nitrogen^2H post peritoneal dialysis |
MCnc |
Periton fld |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
CHEM |
|
12266-3 |
|
|
|
|
Both |
|
|
|
0 |
Urea nit 2h p PD Prt-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p PD; After; Ascites; Ascitic fluid; Ascitis; Blood urea nitrogen; Chemistry; Dialy; Level; Mass concentration; N; N2; Nit; Peritoneal fluid; Point in time; Prt; PST; QNT; Quan; Quant; Quantitative; Random; UN |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
12267-1 |
Urea nitrogen^4H post peritoneal dialysis |
MCnc |
Periton fld |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
CHEM |
|
12267-1 |
|
|
|
|
Both |
|
|
|
0 |
Urea nit 4h p PD Prt-mCnc |
|
|
|
Y |
|
4h p PD; After; Ascites; Ascitic fluid; Ascitis; Blood urea nitrogen; Chemistry; Dialy; Level; Mass concentration; N; N2; Nit; Peritoneal fluid; Point in time; Prt; PST; QNT; Quan; Quant; Quantitative; Random; UN |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
12268-9 |
Urea nitrogen^12H post peritoneal dialysis |
MCnc |
Periton fld |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
CHEM |
|
12268-9 |
|
|
|
|
Both |
|
|
|
0 |
Urea nit 12h p PD Prt-mCnc |
|
|
|
Y |
|
12h p PD; After; Ascites; Ascitic fluid; Ascitis; Blood urea nitrogen; Chemistry; Dialy; Level; Mass concentration; N; N2; Nit; Peritoneal fluid; Point in time; Prt; PST; QNT; Quan; Quant; Quantitative; Random; UN |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
12269-7 |
Urobilinogen |
PrThr |
Urine |
24H |
Ord |
|
|
ACTIVE |
Urobilinogen [Presence] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
12269-7 |
|
|
|
|
Both |
|
|
|
0 |
Urobilinogen 24h Ur Ql |
|
|
|
|
|
1 day; 24 hours; 24HR; Chemistry; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UBG; UR; Urn; Urobili; Urobilngn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1227-8 |
M Ab |
PrThr |
Ser/Plas^Donor |
Pt |
Ord |
|
|
ACTIVE |
M Ab [Presence] in Serum or Plasma from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1227-8 |
|
|
|
|
Observation |
|
|
|
0 |
M Ab SerPl Donr Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Donr; MNSs Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12270-5 |
Uroporphyrin |
PrThr |
Urine |
24H |
Ord |
|
|
ACTIVE |
Uroporphyrin [Presence] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
12270-5 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor 24h Ur Ql |
|
|
|
|
|
1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn; Urophorph |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12271-3 |
Varicella zoster virus Ab |
PrThr |
Ser |
Pt |
Ord |
LA |
|
ACTIVE |
Varicella zoster virus Ab [Presence] in Serum by Latex agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12271-3 |
|
LA |
|
|
Both |
|
|
|
0 |
VZV Ab Ser Ql LA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Shingles; SR; VZ; VZV; Zoster |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12272-1 |
Virus |
Prid |
XXX |
Pt |
Nom |
IF |
|
ACTIVE |
Virus identified in Specimen by Immunofluorescence |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12272-1 |
|
IF |
|
|
Both |
|
|
|
0 |
Virus Spec IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; FA; Fluorescent antibody; Fluoresent; ID; Identity or presence; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |